# Clinical trials recruiting in Montana: 250 (November 2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 250 trials recruiting or not yet recruiting with a site in Montana, as read on November 19, 2026.

## The full list

Clinical trials recruiting in Montana: 250 rows for $12.50, recruiting or not yet recruiting on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. The new rows each week by email, about 4 rows a month: $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/recruiting/state/montana

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 250
- Recruiting or not yet: 250
- Read on: November 19, 2026

## Trials

The 25 newest of 250, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| October 19, 2026 | NCT07881120 | Study of Afimetoran in Adults With Cutaneous Lupus Erythematosus | Beeline Medicines Corporation | Phase 2/3 | Recruiting | Cutaneous Lupus Erythematosus (CLE), Systematic Lupus Erythematosus | 390 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07881120) |
| October 14, 2026 | NCT07872995 | Data-driven Rural Interventions for Vitality and Endurance Pilot Study | McLaughlin Research Institute for Biomedical Sciences, Inc. | Not applicable | Recruiting | Healthy Adult | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07872995) |
| October 1, 2026 | NCT07851025 | Torvutatug Samrotecan Plus Bevacizumab as First-line Maintenance in Non-Homologous Recombination Deficiency (Non-HRD) Positive Advanced... | AstraZeneca | Phase 3 | Recruiting | Epithelial Ovarian Cancer | 950 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07851025) |
| September 29, 2026 | NCT07845500 | A Study to Learn About Switching to a Monthly Study Medicine Called Berobenatide (PF-08653944) to Help Keep Weight Off in People With... | Pfizer | Phase 3 | Recruiting | Obesity, Overweight and/or Obesity, Overweight, Treatment Of Obesity | 660 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07845500) |
| September 11, 2026 | NCT07816367 | A Study to Assess the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine | TriGemX Bio, Inc. | Phase 3 | Recruiting | Migraine | 1,500 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07816367) |
| August 25, 2026 | NCT07784725 | A Study to Evaluate Effect of AZD6234 in Adult Participants With Obesity or Overweight With Weight-related Comorbidity Without Type 2... | AstraZeneca | Phase 3 | Recruiting | Obesity or Overweight | 2,500 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07784725) |
| August 20, 2026 | NCT07775495 | Observational Study of Decentralized Urine Optical Interaction Patterns Associated With Environmental Microplastic and Nanoplastic Exposure | Ecotera Health LLC | Observational | Recruiting | Healthy Adult Participants | 15 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07775495) |
| August 17, 2026 | NCT07766785 | Grow With Grit: A School Nurse-Led SBIRT Pilot for Early Anxiety Detection | McLaughlin Research Institute for Biomedical Sciences, Inc. | Not applicable | Recruiting | Anxiety | 60 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07766785) |
| August 11, 2026 | NCT07758140 | Comparative Self-collection for Cervical Cancer Screening Pivotal Study | Mel Mont Medical | Not applicable | Recruiting | HPV, HPV - Anogenital Human Papilloma Virus Infection | 260 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07758140) |
| August 10, 2026 | NCT07754461 | A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar | Boehringer Ingelheim | Phase 3 | Recruiting | Type 2 Diabetes | 600 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07754461) |
| August 7, 2026 | NCT07752979 | Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities | AbbVie | Phase 2 | Recruiting | Obesity, Overweight | 360 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07752979) |
| August 3, 2026 | NCT07742644 | A Study on the Immune Response and Safety of an Investigational Combined Measles, Mumps, Rubella and Varicella Vaccine, When Given to... | GlaxoSmithKline | Phase 3 | Not yet recruiting | Measles, Mumps, Rubella, Varicella (Chickenpox), Measles-Mumps-Rubella+Chickenpox Vaccine | 1,860 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07742644) |
| July 10, 2026 | NCT07695818 | Testing and Evaluation of the Returning to the Land Intervention to Address and Prevent Substance Misuse | Johns Hopkins Bloomberg School of Public Health | Not applicable | Recruiting | Substance Use, Children, Cultural Factors | 60 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07695818) |
| June 17, 2026 | NCT07654374 | A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2) | Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure Therapeutics | Phase 3 | Recruiting | Obesity, Overweight, Chronic Weight Management, Type2 Diabetes Mellitus | 1,100 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07654374) |
| June 17, 2026 | NCT07654361 | Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1) | Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure Therapeutics | Phase 3 | Recruiting | Obesity, Overweight, Chronic Weight Management | 3,600 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07654361) |
| June 16, 2026 | NCT07650708 | A Multicenter, Open-Label Study to Evaluate Perioperative Treatment of Dry Eye With Miebo® in Subjects Undergoing LASIK | Vance Thompson Vision | Phase 4 | Recruiting | Dry Eye Syndrome (DES), Dry Eye Disease (DED) | 100 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07650708) |
| June 10, 2026 | NCT07638722 | Testing Mosunetuzumab Alone, With Zanubrutinib, or With Polatuzumab Vedotin for Treating Marginal Zone Lymphoma That Came Back or Didn't... | SWOG Cancer Research Network | Phase 2 | Not yet recruiting | Recurrent Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue, Recurrent Nodal Marginal Zone... | 138 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07638722) |
| June 3, 2026 | NCT07623161 | A Study to Compare Elritercept to Placebo in Adults With Myelofibrosis and Anemia Who Are Taking Ruxolitinib | Takeda | Phase 3 | Recruiting | Myelofibrosis, Anemia | 324 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07623161) |
| May 29, 2026 | NCT07615049 | Testing Short-Course Radiation Versus Standard-Course Radiation for Soft Tissue Sarcomas That Need Surgery and Radiation | SWOG Cancer Research Network | Phase 3 | Recruiting | Recurrent Soft Tissue Sarcoma of the Trunk and Extremities, Resectable Soft Tissue Sarcoma of the Trunk and... | 296 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07615049) |
| May 29, 2026 | NCT07614984 | A Clinical Trial of MK-7262 and Enlicitide in Participants With High Lipoprotein(a) (MK-7262-004) | Merck Sharp & Dohme LLC | Phase 2 | Recruiting | Lipoprotein(a) | 750 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07614984) |
| May 8, 2026 | NCT07575399 | Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) to Maridebart Cafraglutide in... | Amgen | Phase 3 | Recruiting | Obesity or Overweight | 300 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07575399) |
| April 30, 2026 | NCT07559175 | A Study to Evaluate Safety and Explore Efficacy of New Lipase NHS7108 in Adult Participants With Exocrine Pancreatic Insufficiency. | Aimmune Nestlé Health Science US R&D, LLC | Phase 2 | Recruiting | Exocrine Pancreatic Insufficiency (EPI), Cystic Fibrosis (CF), Pancreatic Enzyme Abnormality, Pancreatic Diseases | 66 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07559175) |
| April 29, 2026 | NCT07556159 | A Study Evaluating Disease Characteristics and Outcomes in Participants With Asthma in Routine Clinical Practice | Sanofi | Observational | Recruiting | Asthma | 2,500 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07556159) |
| April 20, 2026 | NCT07539987 | Evaluation of a Novel Indoor Air Pollution Intervention Among Older Adults | University of Montana | Not applicable | Not yet recruiting | Cardiovascular Diseases, Blood Pressure, Glycated Hemoglobin (HbA1c), Cholesterol, Cholesterol, HDL, Cholesterol, LDL... | 154 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07539987) |
| April 15, 2026 | NCT07531901 | Evaluating the Feasibility and Reliability of Using Handheld Nebulizers to Conduct Cough Sensitivity Testing With Citric Acid | University of Montana | Not applicable | Recruiting | Cough Reflex Sensitivity | 10 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07531901) |

## Sites with the most of these trials

Sites as the records name them, organizations only.

| Site | City | Trials |
| --- | --- | --- |
| Billings Clinic Cancer Center | Billings | 98 |
| Benefis Sletten Cancer Institute | Great Falls | 87 |
| Community Medical Center | Missoula | 87 |
| Bozeman Health Deaconess Hospital | Bozeman | 84 |
| Community Hospital of Anaconda | Anaconda | 81 |
| Logan Health Medical Center | Kalispell | 78 |
| Saint Patrick Hospital - Community Hospital | Missoula | 42 |
| Great Falls Clinic | Great Falls | 41 |
| Hi-Line Sletten Cancer Center | Havre | 32 |
| Benefis Helena Specialty Center | Helena | 23 |
| Saint Vincent Frontier Cancer Center | Billings | 22 |
| Saint James Community Hospital and Cancer Treatment Center | Butte | 17 |
| Saint Vincent Healthcare | Billings | 14 |
| Intermountain Health West End Clinic | Billings | 10 |
| University of Montana | Missoula | 9 |
| Saint Peter's Community Hospital | Helena | 8 |
| Kalispell Regional Medical Center | Kalispell | 7 |
| Intermountain Health St. Vincent Regional Hospital - Cancer Centers of Montana | Billings | 7 |
| Billings Clinic | Billings | 6 |
| Boeson Research MSO | Missoula | 5 |
| Bozeman Deaconess Hospital | Bozeman | 5 |
| Benefis Healthcare- Sletten Cancer Institute | Great Falls | 5 |
| Community Medical Hospital | Missoula | 4 |
| St. Vincent Frontier Cancer Center-Research | Billings | 4 |
| Boeson Research - Great Falls | Great Falls | 4 |

## By phase

| Phase | Trials |
| --- | --- |
| Phase 1 | 1 |
| Phase 1/2 | 4 |
| Phase 2 | 58 |
| Phase 2/3 | 10 |
| Phase 3 | 113 |
| Phase 4 | 5 |
| Not applicable | 34 |
| Observational | 25 |

## Conditions

| Condition group | Trials |
| --- | --- |
| Carcinoma, Non-Small-Cell Lung | 23 |
| Prostatic Neoplasms | 18 |
| Lung Neoplasms | 16 |
| Breast Neoplasms | 13 |
| Melanoma | 10 |
| Ovarian Neoplasms | 8 |
| Obesity | 7 |
| Colonic Neoplasms | 7 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 7 |
| Leukemia, Myeloid, Acute | 7 |
| Urinary Bladder Neoplasms | 7 |
| Squamous Cell Carcinoma of Head and Neck | 7 |
| Overweight | 6 |
| Rectal Neoplasms | 6 |
| Colorectal Neoplasms | 6 |
| Carcinoma | 6 |
| Pancreatic Neoplasms | 6 |
| Diabetes Mellitus, Type 2 | 5 |
| Hypopharyngeal Neoplasms | 5 |
| Laryngeal Neoplasms | 5 |
| Mouth Neoplasms | 5 |
| Neoplasms | 5 |
| Multiple Myeloma | 5 |
| Endometrial Neoplasms | 5 |
| Stomach Neoplasms | 5 |

## Sponsors with the most

| Sponsor | Trials |
| --- | --- |
| National Cancer Institute (NCI) | 40 |
| SWOG Cancer Research Network | 22 |
| Alliance for Clinical Trials in Oncology | 21 |
| [Merck Sharp & Dohme LLC](https://specstream.ai/data/clinical-trials/company/merck-sharp-and-dohme-llc) | 12 |
| NRG Oncology | 10 |
| [Pfizer](https://specstream.ai/data/clinical-trials/company/pfizer) | 10 |
| [AstraZeneca](https://specstream.ai/data/clinical-trials/company/astrazeneca) | 10 |
| University of Montana | 9 |
| ECOG-ACRIN Cancer Research Group | 8 |
| Montana State University | 6 |
| [GlaxoSmithKline](https://specstream.ai/data/clinical-trials/company/glaxosmithkline) | 4 |
| [Incyte Corporation](https://specstream.ai/data/clinical-trials/company/incyte-corporation) | 4 |
| [Boehringer Ingelheim](https://specstream.ai/data/clinical-trials/company/boehringer-ingelheim) | 3 |
| Canadian Cancer Trials Group | 3 |
| [AbbVie](https://specstream.ai/data/clinical-trials/company/abbvie) | 3 |
| [Genzyme, a Sanofi Company](https://specstream.ai/data/clinical-trials/company/genzyme-a-sanofi-company) | 3 |
| [Bristol-Myers Squibb](https://specstream.ai/data/clinical-trials/company/bristol-myers-squibb) | 2 |
| [Amgen](https://specstream.ai/data/clinical-trials/company/amgen) | 2 |
| [Daiichi Sankyo](https://specstream.ai/data/clinical-trials/company/daiichi-sankyo) | 2 |
| Epiminder America, Inc. | 2 |
| National Institute of Allergy and Infectious Diseases (NIAID) | 2 |
| McLaughlin Research Institute for Biomedical Sciences, Inc. | 2 |
| [Sanofi](https://specstream.ai/data/clinical-trials/company/sanofi) | 2 |
| Inhibrx Biosciences, Inc | 2 |
| [Revolution Medicines, Inc.](https://specstream.ai/data/clinical-trials/company/revolution-medicines-inc) | 2 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in Montana

- [Agricultural cooperatives in Montana, United States](https://specstream.ai/data/businesses/agricultural-cooperatives/montana-united-states)
- [Lodges in Montana, United States](https://specstream.ai/data/businesses/lodges/montana-united-states)
- [Burger restaurants in Montana, United States](https://specstream.ai/data/businesses/burger-restaurants/montana-united-states)
- [Outpatient care facilities in Montana, United States](https://specstream.ai/data/businesses/outpatient-care-facilities/montana-united-states)
- [Dental clinics in Montana, United States](https://specstream.ai/data/businesses/dental-clinics/montana-united-states)
- [Security companies in Montana, United States](https://specstream.ai/data/businesses/security-companies/montana-united-states)
